Bernstein DI, Sawtell NM, Bravo FJ, Dixon DA, et al. Intermittent therapy with helicase-primase inhibitor IM-250 efficiently controls recurrent herpes disease and reduces reactivation of latent HSV. Antiviral Res 2023;219:105733.
PMID: 37858763